The anti-tumor and renoprotection study of E-[c(RGDfK)(2)]/folic acid co-modified nanostructured lipid carrier loaded with doxorubicin hydrochloride/salvianolic acid A

BACKGROUND: Poor in vivo targeting of tumors by chemotherapeutic drugs reduces their anti-cancer efficacy in the clinic. The discovery of over-expressed components on the tumor cell surface and their specific ligands provide a basis for targeting tumor cells. However, the differences in the expressi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Bing, Zhang, Ying, Dang, Wenli, Xing, Bin, Yu, Changxiang, Guo, Pan, Pi, Jiaxin, Deng, Xiuping, Qi, Dongli, Liu, Zhidong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509648/
https://www.ncbi.nlm.nih.gov/pubmed/36153589
http://dx.doi.org/10.1186/s12951-022-01628-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509648/
https://www.ncbi.nlm.nih.gov/pubmed/36153589
http://dx.doi.org/10.1186/s12951-022-01628-x

Ejemplares similares